ADHD medications offer promise in managing menopausal brain fog
An estimated 44% to 60% of perimenopausal women report cognitive changes like forgetfulness and trouble concentrating—also known as brain fog. Despite the effect of these symptoms on quality of life and productivity, there is currently no FDA-approved pharmacological intervention.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Combined estrogen and testosterone therapy increases lumbar spine bone mineral density
United Kingdom
-
Premature menopause associated with higher insulin levels and greater CVD risk
United Kingdom
-
Higher physical activity frequency associated with lower symptom burden in perimenopause
United Kingdom
-
Protecting young skin: A new approach to melanoma prevention for children
United Kingdom
-
Building social and emotional skills in preschool improved life for young adults
United Kingdom
-
Autoimmune disease risk may differ by menopausal hormone therapy formulation
United Kingdom
-
Scientists discover immune pathway behind radiation-induced lung damage
United Kingdom
-
Machine learning can identify older heart failure patients at risk of losing independence
United Kingdom